TITLE

Leukemia arsenal has new drugs

PUB. DATE
January 2013
SOURCE
Oncology Nurse Advisor;January/February 2013, Vol. 4 Issue 1, p13
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the result of the clinical trials conducted by Jorge Cortes, deputy chair of the Department of Leukemia at The University of Texas, about the effectiveness of several leukemia drugs. These include the second-generation tyrosine kinase inhibitor (TKI) Bosulif, a synthetic version of the chronic myelogenous leukemia (CML) homoharringtonine called Omacetaxine and Ponatinib.
ACCESSION #
88088356

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics